Multidisciplinary Team-Based Obesity Treatment in Patients With Diabetes: Current Practices and the State of the Science

Daniel Foster, Shakira Sanchez-Collins, Lawrence J Cheskin, Daniel Foster, Shakira Sanchez-Collins, Lawrence J Cheskin

Abstract

IN BRIEF Rates of obesity and diabetes are growing, as are their costs. Because the two diseases share many key determinants, the paradigms for their treatment overlap. For both, optimal treatment involves a multidisciplinary team following the Chronic Care Model of health care delivery. Combined treatment programs that include 1) a low-calorie diet individualized to patients' preferences, 2) structured exercise that is also tailored to each patient, and 3) psychotherapy induce the largest weight changes in patients with diabetes. Although diet alone can achieve weight loss, exercise and cognitive behavioral therapy components can enhance the effects of dietary modification. A multidisciplinary team that includes a physician with expertise in pharmacotherapy, a nurse and/or nurse practitioner, a dietitian, an exercise physiologist, and a psychologist can provide a comprehensive weight loss program combining the most effective interventions from each discipline.

References

    1. Ogden C, Carroll M, Fryar C, Flegal K. Prevalence of obesity among adults and youth: United States 2011–2014. NCHS Data Brief 2015;Nov;1–8
    1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2017;289:187–193
    1. Flegal KM, Kit BK, Orpana H. Association of all-cause mortality with overweight and obesity using standard body mass index categories. JAMA 2017;309:71–82
    1. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics 2015;33:673–689
    1. Mallory Leung M, Carlsson NP, Colditz GA, Chang S. The burden of obesity on diabetes in the United States: medical expenditure panel survey, 2008 to 2012. Value Health 2017;20:77–84
    1. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer and service specific estimates. Health Aff (Millwood) 2009;28:822–831
    1. Centers for Disease Control and Prevention National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta, Ga., U.S. Department of Health and Human Services, 2014
    1. Stokes A, Preston SH. Deaths attributable to diabetes in the United States: comparison of data sources and estimation approaches. PLoS One 2017;12:e0170219
    1. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract 2010;87:15–19
    1. Deshpande A, Harris-Haynes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008;88:1254–1264
    1. Cordain L, Eaton SB, Sebastian A, et al. . Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005;81:341–354
    1. McEvoy CT, Cardwell CR, Woodside JV, Young IS, Hunter SJ, Mckinley MC. A posteriori dietary patterns are related to risk of type 2 diabetes: findings from a systematic review and meta-analysis. J Acad Nutr Diet 2014;114:1759–1775.e4
    1. Cefalu WT, Bray GA, Home PD, et al. . Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care editors’ expert forum. Diabetes Care 2015;38:1567–1582
    1. Astrup A, Finer N. Redefining type 2 diabetes: “diabesity” or “obesity dependent diabetes mellitus”? Obes Rev 2000;20:57–59
    1. Aucott L, Poobalan A, Smith WCS, et al. . Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes: a systematic review. Diabetes Obes Metab 2004;6:85–94
    1. Dixon JB. Advances in managing obesity. Nature 2016;12:215–216
    1. Mooradian AD. Obesity: a rational target for managing diabetes mellitus. Growth Horm IGF Res 2001;11(Suppl. A):S79–S83
    1. Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 2013;273:219–234
    1. Sjöholm K, Pajunen P, Jacobson P, et al. . Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study. Diabetologia 2015;58:1448–1453
    1. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. ; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673–1679
    1. Diabetes Prevention Program Research Group The Diabetes Prevention Program: description of lifestyle intervention. Diabetes Care 2005;25:2165–2171
    1. Gregg EW, Chen H, Wagenknecht LE, et al. . Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012;308:2489–2496
    1. Jensen MD, Ryan DH, Apovian CM, et al. . AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014;129(Suppl. 2):S102–S138
    1. McGill M, Felton A-M. New global recommendations: a multidisciplinary approach to improving outcomes in diabetes. Prim Care Diabetes 2007;1:49–55
    1. Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes. Ann Intern Med 2016;164:542–552
    1. Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood) 2009;28:75–86
    1. Wielawski IM. Improving chronic illness care. In To Improve Health and Health Care. Isaacs S, Knickman J, Eds. San Francisco, Calif., Jossey-Bass, 2006, p. 1–17
    1. McCallin A. Interdisciplinary practice: a matter of teamwork: an integrated literature review. J Clin Nurs 2001;10:419–428
    1. Ouwens M, Wollersheim HUB, Hermens R, Hulscher M. Integrated care programmes for chronically ill patients: a review of systematic reviews. Int J Qual Health Care 2005;17:141–146
    1. Mickan SM, Rodger SA. Effective health care teams: a model of six characteristics developed from shared perceptions. J Interprof Care 2005;19:358–370
    1. Aschner P, Lasalle J, Mcgill M; Global Partnership for Effective Diabetes Management. The team approach to diabetes management: partnering with patients. Int J Clin Pract Suppl 2007;61:22–30
    1. VanGaal L, Scheen A. Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care 2015;38:1161–1172
    1. Franz MJ. The dilemma of weight loss in diabetes. Diabetes Spectr 2007;20:133–136
    1. Bray GA, Frühbeck G, Ryan DH, Wilding JPH. Management of obesity. Lancet 2016;387:1947–1956
    1. Yu GC, Beresford R. Implementation of a chronic illness model for diabetes care in a family medicine residency program. J Gen Intern Med 2010;25:615–619
    1. Golay A, Fossati M, Deletraz M, De Luzy F, Howles MN, Ybarra J. Multidisciplinary approach to obesity treatment. Diabetes Obes Metab 2003;5:274–279
    1. Bernstein KM, Manning DA, Julian RM. Multidisciplinary teams and obesity: role of the modern patient-centered medical home. Prim Care 2016;43:53–59
    1. Ryan DH. Guidelines for obesity management. Endocrinol Metab Clin North Am 2016;45:501–510
    1. De Feo P, Fatone C, Burani P, et al. . An innovative model for changing the lifestyles of persons with obesity and/or type 2 diabetes mellitus. J Endocrinol Invest 2011;34:e349–e354.
    1. Pappachan JM, Viswanath AK. Medical management of diabesity: do we have realistic targets? Curr Diab Rep 2017;17:4.
    1. Wing R, Marcus MP, Epstein LH, Salata R. Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 1987;10:563–566
    1. Guare JC, Wing RR, Grant A. Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss. Obes Res 1995;3:329–335
    1. Pi-Sunyer FX. Weight loss in type 2 diabetic patients. Diabetes Care 2005;28:1526–1527
    1. U.K. Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837–853
    1. Nair KS, Halliday D, Garrow JS. Increased energy expenditure in poorly controlled type 1 (insulin-dependent) diabetic patients. Diabetologia 1984;27:13–16
    1. Bogardus C, Taskinen MR, Zawadzki J, Lillioja S, Mott D, Howard BV. Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes 1986;35:1–5
    1. Panel on Macronutrients; Panel on the Definition of Dietary Fiber; Subcommittee on Upper Reference Levels of Nutrients; Subcommittee on Interpretation and Uses of Dietary Reference Intakes; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; Food and Nutrition Board; Institute of Medicine . Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, D.C., National Academies Press, 2002
    1. U.S. Department of Health and Human Services 2008 Physical Activity Guidelines for Americans [Internet]. Available from . Accessed 8 February 2017
    1. American Diabetes Association Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(Suppl. 1):S61–S78
    1. Goday A, Bellido D, Sajoux I, et al. . Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes 2016;6:e230
    1. Elhayany A, Lustman A, Abel R, Attal-Singer J, Vinker S. A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab 2010;12:204–209
    1. Barnard ND, Cohen J, Jenkins DJ, et al. . A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. Am J Clin Nutr 2009;89:1588S–1596S
    1. Fabricatore AN, Wadden TA, Ebbeling CB, et al. . Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: a randomized controlled trial. Diabetes Res Clin Pract 2011;92:37–45
    1. Guldbrand H, Lindström T, Dizdar B, et al. . Randomization to a low-carbohydrate diet advice improves health related quality of life compared with a low-fat diet at similar weight-loss in type 2 diabetes mellitus. Diabetes Res Clin Pract 2014;106:221–227
    1. Sigal RJ, Kenny GP, Boulé NG, et al. . Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes. Ann Intern Med 2007;147:357–369
    1. Lucotti P, Monti LD, Setola E, et al. . Aerobic and resistance training effects compared to aerobic training alone in obese type 2 diabetic patients on diet treatment. Diabetes Res Clin Pract 2011;94:395–403
    1. Kraus WE, Houmard JA, Duscha BD, et al. . Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002;347:1483–1492
    1. Snel M, Gastaldelli A, Ouwens DM, et al. . Effects of adding exercise to a 16-week very low-calorie diet in obese, insulin-dependent type 2 diabetes mellitus patients. J Clin Endocrinol Metab 2012;97:2512–2520
    1. Wycherley TP, Noakes M, Clifton P, Cleanthous X, Keogh JB, Brinkworth GD. A high-protein diet with resistance exercise training improves weight loss and body composition in overweight and obese patients with type 2 diabetes. Diabetes Care 2010;33:969–976
    1. Di Loreto C, Fanelli C, Lucidi P, et al. . Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care 2005;28:1295–1302
    1. Umpierre D, Ribeiro PAB, Kramer CK, et al. . Physical activity advice only or structured exercise training and association with HbA 1c levels in type 2 diabetes. JAMA 2011;305:1790–1799
    1. Fabricatore AN. Behavior therapy and cognitive-behavioral therapy of obesity: is there a difference? J Am Diet Assoc 2007;107:92–99
    1. Hollon SD. What is cognitive behavioural therapy and does it work? Curr Opin Neurobiol 1998;8:289–292
    1. Dorsten BVan, Lindley EM. Cognitive and behavioral approaches in the treatment of obesity. Med Clin North Am 2011;95:971–988
    1. Kelley CP, Sbrocco G, Sbrocco T. Behavioral modification for the management of obesity. Prim Care 2016;43:159–175
    1. Grilo CM, Masheb RM, Wilson GT, Gueorguieva R, White MA. Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial. J Consult Clin Psychol 2011;79:675–685
    1. Painot D, Jotterand S, Kammer A, Fossati M, Golay A. Simultaneous nutritional cognitive-behavioural therapy in obese patients. Patient Educ Couns 2001;42:47–52
    1. Cresci B, Tesi F, La Ferlita T, et al. . Group versus individual cognitive-behavioural treatment for obesity: results after 36 months. Eat Weight Disord 2007;12:147–153
    1. Wadden T, Osei S. The treatment of obesity: an overview. In Handbook of Obesity Treatment. Wadden TA, Stunkard AJ, Eds. New York, Guilford Press, 2002, p. 229–248
    1. Triplitt C. Drug interactions of medications commonly used in diabetes. Diabetes Spectr 2006;19:202–211
    1. Flood BL, Constance A. Diabetes exercise safety. Am J Nurs 2002;102:47–55
    1. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005;118(Suppl. 5):27S–34S
    1. Yun LWH, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005;38:432–438
    1. Gatto N, Mohr DC, Goodkin DE, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997;54:531–533
    1. DiMatteo M. Social support and patient adherence to medical treatment: a meta-analysis. Heal Psychol 2004;23:207–218
    1. Vlasnik J, Aliotta S, Bonnie D. Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager 2005;16:47–51
    1. Pham S, Gancel A, Scotte M, et al. . Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study. J Obes 2014;2014:638203.
    1. Kumar AA, Palamaner Subash Shantha G, Kahan S, Samson RJ, Boddu ND, Cheskin LJ. Intentional weight loss and dose reductions of anti-diabetic medications: a retrospective cohort study. PLoS One 2012;7:e32395.
    1. Herring LY, Stevinson C, Carter P, et al. . The effects of supervised exercise training 12–24 months after bariatric surgery on physical function and body composition: a randomised controlled trial. Int J Obes (Lond) 2017;41:909–916
    1. Kalarchian M, Turk M, Elliott J, Gourash W. Lifestyle management for enhancing outcomes after bariatric surgery. Curr Diab Rep 2014;14:540.
    1. Liu H, Hu C, Zhang X, Jia W. Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Investig. Epub ahead of print on 23 April 2017 (DOI: 10.1111/jdi.12687)
    1. Kashyap SR, Gatmaitan P, Brethauer S, Schauer P. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients. Cleve Clin J Med 2010;77:468–476
    1. Ardestani A, Rhoads D, Tavakkoli A. Insulin cessation and diabetes remission after bariatric surgery in adults with insulin-treated type 2 diabetes. Diabetes Care 2015;38:659–664
    1. Norris SL, Zhang X, Avenell A, et al. . Long-term effectiveness of lifestyle and behavioral weight loss interventions in adults with type 2 diabetes: a meta-analysis. Am J Med 2004;117:762–774

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel